|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 498/18 | |
| A61K 31/439 | |||
| A61P 35/00 |
| (11) | Number of the document | 3328867 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16751665.7 |
| Date of filing the European patent application | 2016-07-27 | |
| (97) | Date of publication of the European application | 2018-06-06 |
| (45) | Date of publication and mention of the grant of the patent | 2020-11-11 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2016/054483 |
| Date | 2016-07-27 |
| (87) | Number | WO 2017/021823 |
| Date | 2017-02-09 |
| (30) | Number | Date | Country code |
| 201562199418 P | 2015-07-31 | US | |
| 201662352349 P | 2016-06-20 | US |
| (72) |
BIRCH, Melissa J., GB
PENCHEVA, Klimentina Dimitrova, GB
|
| (73) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017,
US
|
| (54) | CRYSTALLINE FORM OF LORLATINIB FREE BASE |
| CRYSTALLINE FORM OF LORLATINIB FREE BASE |